help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khandwala, H. M.
Right arrow Articles by Friend, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khandwala, H. M.
Right arrow Articles by Friend, K. E.
Endocrine Reviews 21 (3): 215-244
Copyright © 2000 by The Endocrine Society

The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth

Hasnain M. Khandwala, Ian E. McCutcheon, Allan Flyvbjerg and Keith E. Friend

Section of Endocrine Neoplasia & Hormonal Disorders (H.M.K., K.E.F.) and the Department of Neurosurgery (I.E.M.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; and Medical Department M (Diabetes and Endocrinology) (A.F.), Aarhus Kommunehospital, Aarhus, DK-8000 Denmark

Several decades of basic and clinical research have demonstrated that there is an association between the insulin-like growth factors (IGFs) and neoplasia. We begin with a brief discussion of the function and regulation of expression of the IGFs, their receptors and the IGF-binding proteins (IGFBPs). A number of investigational interventional strategies targeting the GH or IGFs are then reviewed. Finally, we have assembled the available scientific knowledge about this relationship for each of the major tumor types. The tumors have been grouped together by organ system and for each of the major tumors, various key elements of the relationship between IGFs and tumor growth are discussed. Specifically these include the presence or absence of autocrine IGF-I and IGF-II production; presence or absence of IGF-I and IGF-II receptor expression; the expression and functions of the IGFBPs; in vitro and in vivo experiments involving therapeutic interventions; and available results from clinical trials evaluating the effect of GH/IGF axis down-regulation in various malignancies.




This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
G. Cao, H. Lu, J. Feng, J. Shu, D. Zheng, and Y. Hou
Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population
Jpn. J. Clin. Oncol., April 1, 2008; 38(4): 308 - 316.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
P. D. Ryan and P. E. Goss
The Emerging Role of the Insulin-Like Growth Factor Pathway as a Therapeutic Target in Cancer
Oncologist, January 1, 2008; 13(1): 16 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
J. W. B de Groot, B. Rikhof, J. van Doorn, H. J G Bilo, M. A Alleman, A. H Honkoop, and W. T A van der Graaf
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases
Endocr. Relat. Cancer, December 1, 2007; 14(4): 979 - 993.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. C van der Pols, C. Bain, D. Gunnell, G. Davey Smith, C. Frobisher, and R. M Martin
Childhood dairy intake and adult cancer risk: 65-y follow-up of the Boyd Orr cohort
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1722 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Siahpush, T. L. Vaughan, J. N. Lampe, R. Freeman, S. Lewis, R. D. Odze, P. L. Blount, K. Ayub, P. S. Rabinovitch, B. J. Reid, et al.
Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2387 - 2395.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
K. R. Rarick, M. A. Pikosky, A. Grediagin, T. J. Smith, E. L. Glickman, J. A. Alemany, J. S. Staab, A. J. Young, and B. C. Nindl
Energy flux, more so than energy balance, protein intake, or fitness level, influences insulin-like growth factor-I system responses during 7 days of increased physical activity
J Appl Physiol, November 1, 2007; 103(5): 1613 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Chi-Hang Li and R. Li
RAV12 Accelerates the Desensitization of Akt/PKB Pathway of Insulin-like Growth Factor I Receptor Signaling in COLO205
Cancer Res., September 15, 2007; 67(18): 8856 - 8864.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. K. Rowinsky, H. Youssoufian, J. R. Tonra, P. Solomon, D. Burtrum, and D. L. Ludwig
IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor
Clin. Cancer Res., September 15, 2007; 13(18): 5549s - 5555s.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, I-M. Lee, J. E. Buring, M. N. Pollak, and S. E. Hankinson
Insulin-like Growth Factors and Ovarian Cancer Risk: A Nested Case-Control Study in Three Cohorts
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1691 - 1695.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Feng, I. U. Agoulnik, N. V. Bogatcheva, A. A. Kamat, B. Kwabi-Addo, R. Li, G. Ayala, M. M. Ittmann, and A. I. Agoulnik
Relaxin Promotes Prostate Cancer Progression
Clin. Cancer Res., March 15, 2007; 13(6): 1695 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
P. H M Peeters, A. Lukanova, N. Allen, F. Berrino, T. Key, L. Dossus, S. Rinaldi, C. H van Gils, H B. Bueno-de-Mesquita, H. Boeing, et al.
Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC)
Endocr. Relat. Cancer, March 1, 2007; 14(1): 81 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts
Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. Vrieling, M. A. Rookus, E. Kampman, J. M. G. Bonfrer, C. M. Korse, J. van Doorn, J. W. Lampe, A. Cats, B. J. M. Witteman, F. E. van Leeuwen, et al.
Isolated Isoflavones Do Not Affect the Circulating Insulin-Like Growth Factor System in Men at Increased Colorectal Cancer Risk
J. Nutr., February 1, 2007; 137(2): 379 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Yin, F. Vreeland, L. J. Schaaf, R. Millham, B. A. Duncan, and A. Sharma
Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy
Clin. Cancer Res., February 1, 2007; 13(3): 1000 - 1009.
[Abstract] [Full Text] [PDF]

Home page
 Biol Res NursHome page
C. Power, S. K. Miller, and P. T. Alpert
Promising New Causal Explanations for Obesity and Obesity-Related Diseases
Biol Res Nurs, January 1, 2007; 8(3): 223 - 233.
[Abstract] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C. ALEXIA, M. BRAS, G. FALLOT, N. VADROT, F. DANIEL, M. LASFER, H. TAMOUZA, and A. GROYER
Pleiotropic Effects of PI-3' Kinase/Akt Signaling in Human Hepatoma Cell Proliferation and Drug-Induced Apoptosis
Ann. N.Y. Acad. Sci., December 1, 2006; 1090(1): 1 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
J Riedemann and V M Macaulay
IGF1R signalling and its inhibition
Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S33 - S43.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Ergun-Longmire, A. C. Mertens, P. Mitby, J. Qin, G. Heller, W. Shi, Y. Yasui, L. L. Robison, and C. A. Sklar
Growth Hormone Treatment and Risk of Second Neoplasms in the Childhood Cancer Survivor
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3494 - 3498.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J.-W. Chen, M. F Nielsen, A. Caumo, H. Vilstrup, J. S. Christiansen, and J. Frystyk
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.
Eur. J. Endocrinol., August 1, 2006; 155(2): 285 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Wang, G. Chakravarty, S. Kim, Y. D. Yazici, M. N. Younes, S. A. Jasser, A. A. Santillan, C. D. Bucana, A. K. El-Naggar, and J. N. Myers
Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma
Clin. Cancer Res., August 1, 2006; 12(15): 4755 - 4765.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. K. Parsons, H. B. Carter, A. W. Partin, B. G. Windham, E. J. Metter, L. Ferrucci, P. Landis, and E. A. Platz
Metabolic Factors Associated with Benign Prostatic Hyperplasia
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2562 - 2568.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Cappuzzo, L. Toschi, G. Tallini, G. L. Ceresoli, I. Domenichini, S. Bartolini, G. Finocchiaro, E. Magrini, G. Metro, A. Cancellieri, et al.
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
Ann. Onc., July 1, 2006; 17(7): 1120 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Severi, H. A. Morris, R. J. MacInnis, D. R. English, W. D. Tilley, J. L. Hopper, P. Boyle, and G. G. Giles
Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1137 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 Genome Res.Home page
M. F. Rudd, E. L. Webb, A. Matakidou, G. S. Sellick, R. D. Williams, H. Bridle, T. Eisen, R. S. Houlston, and the GELCAPS Consortium
Variants in the GH-IGF axis confer susceptibilityto lung cancer.
Genome Res., June 1, 2006; 16(6): 693 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Spence, A. L. Shaffer, L. M. Staudt, S. Amde, S. Manney, C. Terry, K. Weisz, and P. Nissley
Transformation of Late Passage Insulin-Like Growth Factor-I Receptor Null Mouse Embryo Fibroblasts by SV40 T Antigen.
Cancer Res., April 15, 2006; 66(8): 4233 - 4239.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. L. Gable, B. A. Maddux, C. Penaranda, M. Zavodovskaya, M. J. Campbell, M. Lobo, L. Robinson, S. Schow, J. A. Kerner, I. D. Goldfine, et al.
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
Mol. Cancer Ther., April 1, 2006; 5(4): 1079 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
M. Hopfner, V. Baradari, A. Huether, C. Schofl, and H. Scherubl
The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 135 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Lin, P. M. Ridker, N. Rifai, I-M. Lee, J. E. Manson, J. E. Buring, and S. M. Zhang
A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women.
Cancer Res., March 1, 2006; 66(5): 2869 - 2875.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
J Ayuk and M C Sheppard
Growth hormone and its disorders
Postgrad. Med. J., January 1, 2006; 82(963): 24 - 30.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
P. W. Parodi
Dairy Product Consumption and the Risk of Breast Cancer
J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Canzian, J. D. McKay, R. J. Cleveland, L. Dossus, C. Biessy, C. Boillot, S. Rinaldi, M. Llewellyn, V. Chajes, F. Clavel-Chapelon, et al.
Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2316 - 2325.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler
Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. A. Quigley, A. M. Gill, B. J. Crowe, K. Robling, J. J. Chipman, S. R. Rose, J. L. Ross, F. G. Cassorla, A. M. Wolka, J. M. Wit, et al.
Safety of Growth Hormone Treatment in Pediatric Patients with Idiopathic Short Stature
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5188 - 5196.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Keller, A. V. Schally, K. Groot, G. L. Toller, A. Havt, F. Koster, P. Armatis, G. Halmos, M. Zarandi, J. L. Varga, et al.
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone
PNAS, July 26, 2005; 102(30): 10628 - 10633.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. E. Sonntag, C. S. Carter, Y. Ikeno, K. Ekenstedt, C. S. Carlson, R. F. Loeser, S. Chakrabarty, S. Lee, C. Bennett, R. Ingram, et al.
Adult-Onset Growth Hormone and Insulin-Like Growth Factor I Deficiency Reduces Neoplastic Disease, Modifies Age-Related Pathology, and Increases Life Span
Endocrinology, July 1, 2005; 146(7): 2920 - 2932.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. B. Engel, G. Keller, A. V. Schally, G. L. Toller, K. Groot, A. Havt, P. Armatis, M. Zarandi, J. L. Varga, and G. Halmos
Inhibition of Growth of Experimental Human Endometrial Cancer by an Antagonist of Growth Hormone-Releasing Hormone
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3614 - 3621.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Liao, Y. Hu, D. J. Herrick, and G. Brewer
The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia Cells
J. Biol. Chem., May 6, 2005; 280(18): 18517 - 18524.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, C. Morin, and J. Brisson
Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1065 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Arturi, E. Ferretti, I. Presta, T. Mattei, A. Scipioni, D. Scarpelli, R. Bruno, L. Lacroix, E. Tosi, A. Gulino, et al.
Regulation of Iodide Uptake and Sodium/Iodide Symporter Expression in the MCF-7 Human Breast Cancer Cell Line
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2321 - 2326.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. H. Jee, H. Ohrr, J. W. Sull, J. E. Yun, M. Ji, and J. M. Samet
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
JAMA, January 12, 2005; 293(2): 194 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Lukanova and R. Kaaks
Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus
The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Terzolo, G. Reimondo, M. Gasperi, R. Cozzi, R. Pivonello, G. Vitale, A. Scillitani, R. Attanasio, E. Cecconi, F. Daffara, et al.
Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 84 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
L. Lynch, P. I. Vodyanik, D. Boettiger, and M. A. Guvakova
Insulin-like Growth Factor I Controls Adhesion Strength Mediated by {alpha}5{beta}1 Integrins in Motile Carcinoma Cells
Mol. Biol. Cell, January 1, 2005; 16(1): 51 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C. ALEXIA, M. LASFER, and A. GROYER
Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines
Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 219 - 229.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Liao, M. Patel, Y. Hu, S. Charles, D. J. Herrick, and G. Brewer
Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells
J. Biol. Chem., November 19, 2004; 279(47): 48716 - 48724.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Gronbaek, A. Flyvbjerg, L. Mellemkjaer, A. Tjonneland, J. Christensen, H. Toft Sorensen, and K. Overvad
Serum Insulin-Like Growth Factors, Insulin-Like Growth Factor Binding Proteins, and Breast Cancer Risk in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1759 - 1764.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
S. M. Enger, J. M. Greif, J. Polikoff, and M. Press
Body Weight Correlates With Mortality in Early-Stage Breast Cancer
Arch Surg, September 1, 2004; 139(9): 954 - 960.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Svensson, B.-A. Bengtsson, T. Rosen, A. Oden, and G. Johannsson
Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3306 - 3312.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. A. Heinlein and C. Chang
Androgen Receptor in Prostate Cancer
Endocr. Rev., April 1, 2004; 25(2): 276 - 308.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. F. Muller, J. J. Kopchick, A. Flyvbjerg, and A. J. van der Lely
Growth Hormone Receptor Antagonists
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1503 - 1511.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, L. Shaw, M. White, and D. Mukhopadhyay
Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells
J. Biol. Chem., February 6, 2004; 279(6): 3941 - 3948.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Endocr. Rev., February 1, 2004; 25(1): 102 - 152.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. Y. Pan, K. C. Johnson, A.-M. Ugnat, S. W. Wen, and Y. Mao
Association of Obesity and Cancer Risk in Canada
Am. J. Epidemiol., February 1, 2004; 159(3): 259 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham
Association between Insulin-Like Growth Factor-I: Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 166 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. A. Kanashiro, A. V. Schally, K. Groot, P. Armatis, A. L. F. Bernardino, and J. L. Varga
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin
PNAS, December 23, 2003; 100(26): 15836 - 15841.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
J. M. Harper, A. T. Galecki, D. T. Burke, S. L. Pinkosky, and R. A. Miller
Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice
Physiol Genomics, September 29, 2003; 15(1): 44 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
Y. Mao, S. Pan, S. W. Wen, and K. C. Johnson
Physical Activity and the Risk of Lung Cancer in Canada
Am. J. Epidemiol., September 15, 2003; 158(6): 564 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. M. Y. Nomura, G. N. Stemmermann, J. Lee, and M. N. Pollak
Serum Insulin-like Growth Factor I and Subsequent Risk of Colorectal Cancer among Japanese-American Men
Am. J. Epidemiol., September 1, 2003; 158(5): 424 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Maloney, J. L. McLaughlin, N. E. Dagdigian, L. M. Garrett, K. M. Connors, X.-M. Zhou, W. A. Blattler, T. Chittenden, and R. Singh
An Anti-Insulin-like Growth Factor I Receptor Antibody That Is a Potent Inhibitor of Cancer Cell Proliferation
Cancer Res., August 15, 2003; 63(16): 5073 - 5083.
[Abstract] [Full Text] [PDF]